Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Child & Adolescent Psychiatry
•
Obsessive-Compulsive Disorders
How do you address parental anxiety/resistance to ERP treatment in younger children?
Related Questions
When do you consider adding an antipsychotic for SSRI-refractory OCD, and which agent do you typically choose first?
What medications have you found to be effective for childhood-onset speech fluency disorder?
What medication management strategies exist for children with neurodevelopmental disorders who respond poorly to stimulants and have intolerable side effects on antipsychotics?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
What therapeutic approaches have you found effective for athletes with anorexia nervosa whose eating disorder symptoms are intertwined with sport-driven weight pressures?
When do you consider the use of N-acetylcysteine (NAC) in patients with trichotillomania?
Would you consider prescribing NAC for a patient with OCD and a documented sulfa allergy?
How do you introduce patients with obsessive-compulsive disorder to the concept of exposure and response prevention (ERP) therapy when they may be hesitant to engage in exposure-based work?
How do you address non-adherence to medical treatment in adolescent and young adult oncology patients due to mental illness such as depression?
For children under the age of 7 with ADHD who continue to have significant impairment with behavioral interventions, how do you decide between starting with a stimulant vs starting with an alpha agonist?